open access

Vol 7, No 2 (2003)
Review paper
Published online: 2003-03-24
Get Citation

Malignant Hypertension - Does It Still Exist?

Andrzej Januszewicz, Aleksander Prejbisz, Tomasz Dobrucki
Nadciśnienie tętnicze 2003;7(2):115-119.

open access

Vol 7, No 2 (2003)
REVIEV
Published online: 2003-03-24

Abstract

Malignant hypertension is an extremely severe form of hypertension in which intense vasoconstriction occurs as a result of association mechanisms, including an increase in vasoconstrictors, a decrease in vasodilators, and increased activity of the sympathetic nervous and renin angiotensin aldosteron systems and is associated with endothelium dysfunction. Malignant hypertension is rapidly fatal unless antihypertensive treatment is instituted. It has been reported that malignant hypertension has become a rare condition with an improved prognosis since the advent of effective antihypertensive therapy.

Abstract

Malignant hypertension is an extremely severe form of hypertension in which intense vasoconstriction occurs as a result of association mechanisms, including an increase in vasoconstrictors, a decrease in vasodilators, and increased activity of the sympathetic nervous and renin angiotensin aldosteron systems and is associated with endothelium dysfunction. Malignant hypertension is rapidly fatal unless antihypertensive treatment is instituted. It has been reported that malignant hypertension has become a rare condition with an improved prognosis since the advent of effective antihypertensive therapy.
Get Citation

Keywords

malignant hypertension; target organ damage; endothelium; renin-angiotensin-aldosteron system

About this article
Title

Malignant Hypertension - Does It Still Exist?

Journal

Arterial Hypertension

Issue

Vol 7, No 2 (2003)

Article type

Review paper

Pages

115-119

Published online

2003-03-24

Page views

922

Article views/downloads

1829

Bibliographic record

Nadciśnienie tętnicze 2003;7(2):115-119.

Keywords

malignant hypertension
target organ damage
endothelium
renin-angiotensin-aldosteron system

Authors

Andrzej Januszewicz
Aleksander Prejbisz
Tomasz Dobrucki

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl